Delfi Diagnostics
PrivateLast Round
VC Round
Dec 18, 2025
Total Funding Raised
$330.5M
Company Overview
Delfi Diagnostics is a biotechnology company that develops high-performance, accessible blood-based tests for the early detection of cancer using machine learning to analyze cell-free DNA fragmentation patterns.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delfi Diagnostics Comparables
Compare Delfi Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PrognomiQ | 86% | |
| Harbinger Health | 84% | |
| Mercy BioAnalytics | 82% |
Delfi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 18, 2025 | ||||
| Corporate Funding | Jun 4, 2024 | ||||
| Series B | Jul 18, 2022 | ||||
| Series A | Jan 12, 2021 | ||||
| Seed | Aug 1, 2019 |
Delfi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Series B |
| Brown Advisory | Series B |
| Bollinger Investment Group | Series A |
| TD Securities | Series B, Series A |
| Blue Owl Capital | Series B, Series A |
| Osage University Partners | Series B |
| OrbiMed | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Five poster presentations at AACR 2026 Annual Meeting.
- Apr 6, 2026
Showcasing advances to whole-genome cfDNA platform at AACR 2026.
Delfi Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Delfi Diagnostics's valuation, stock price, and market status.
Is Delfi Diagnostics a public or private company?
Delfi Diagnostics is a private company.
What is the current stock price of Delfi Diagnostics?
Delfi Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Delfi Diagnostics worth (valuation)?
Valuation information for Delfi Diagnostics is not publicly available.
Can I buy Delfi Diagnostics stock?
Delfi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Delfi Diagnostics's last funding round?
Delfi Diagnostics's most recent funding round was Series B on July 18, 2022.
Who are the main investors in Delfi Diagnostics?
Key investors in Delfi Diagnostics include OrbiMed, DFJ Growth, Menlo Ventures.
Will Delfi Diagnostics IPO soon?
No public IPO plans have been announced for Delfi Diagnostics.
How can I track Delfi Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delfi Diagnostics's secondary market activity and sign up for updates.